The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Climate and COVID-19 transmission: a cross-sectional study in Africa
    Ousmane Koanda
    Roland Yonaba
    Fowé Tazen
    Héla Karoui
    Mohamed Lamine Sidibé
    Babacar Lèye
    Mamadou Diop
    Harinaivo Anderson Andrianisa
    Harouna Karambiri
    Scientific Reports, 13
  • [42] Climate and COVID-19 transmission: a cross-sectional study in Africa
    Koanda, Ousmane
    Yonaba, Roland
    Tazen, Fowe
    Karoui, Hela
    Sidibe, Mohamed Lamine
    Leye, Babacar
    Diop, Mamadou
    Andrianisa, Harinaivo Anderson
    Karambiri, Harouna
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Risk perceptions of COVID-19 in Beijing: a cross-sectional study
    Liu, Qing
    Tan, Yiyang
    Zhu, Zheng
    Zhang, Jiawei
    Fu, Yaqun
    Wang, Quan
    Nie, Zhijie
    Yang, Li
    Li, Xiaoguang
    FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [44] COVID-19 and young Italians: results of a cross-sectional study
    Lia, L.
    Dorelli, B.
    Marte, M.
    Chiappetta, M.
    Faticoni, A.
    Paoli, L. Lucaccini
    Grassucci, D.
    Gelardini, M.
    Ardizzone, C.
    La Torre, G.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30
  • [45] COVID-19 Vaccine Hesitancy in Pregnancy: A Cross-Sectional Study
    Ercan, Aysegul
    Senol, Ebru
    Firat, Aysun
    JOURNAL OF CLINICAL OBSTETRICS AND GYNECOLOGY, 2022, 32 (01): : 7 - 12
  • [46] COVID-19 risk perceptions in Japan: a cross-sectional study
    Chiba, Asako
    Nakata, Taisuke
    Nguyen, Thuy Linh
    Takaku, Reo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [47] COVID-19 deaths among nurses: a cross-sectional study
    Keles, E.
    Bektemur, G.
    Baydili, K. N.
    OCCUPATIONAL MEDICINE-OXFORD, 2021, 71 (03): : 131 - 135
  • [48] Resilience After COVID-19: A Descriptive, Cross-Sectional Study
    Fernandez-Alonso, Victor
    Rodriguez-Fernandez, Sara
    Secadas-Rincon, Laura
    Perez-Gomez, Manuela
    Moro-Tejedor, Maria Nieves
    Salcedo, Magdalena
    CLINICAL NURSING RESEARCH, 2023, 32 (03) : 618 - 628
  • [49] Information and Misinformation on COVID-19 a Cross-Sectional Survey Study
    Gupta, Latika
    Gasparyan, Armen Yuri
    Misra, Durga Prasanna
    Agarwal, Vikas
    Zimba, Otena
    Yessirkepov, Marten
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (27)
  • [50] Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study
    João Eudes Magalhães
    Pedro A. Sampaio Rocha-Filho
    Journal of NeuroVirology, 2023, 29 : 472 - 478